Latest News

The Gorman-Rupp Company reported first-quarter 2026 results, with sales of US$176.59 million and net income of US$17.84 million, both higher than the same period a year earlier. Basic earnings per share from continuing operations rose to US$0.68 from US$0.46, underscoring how revenue growth is feeding through to stronger profitability. Next, we’ll examine how this earnings-driven improvement in profitability shapes Gorman-Rupp’s investment narrative for investors assessing its long-term...

Pathward Financial (CASH) gave investors fresh numbers to assess with its latest quarterly earnings, showing lower net interest income but higher earnings per share and continued progress in tax services and commercial finance. See our latest analysis for Pathward Financial. The recent earnings release appears to have reinforced positive sentiment, with the 30 day share price return of 7.94% and 90 day share price return of 23.29% contributing to a 1 year total shareholder return of 25.09%...

Why Nutanix is Back on Investor Radar Recent commentary around Nutanix (NTNX) has zeroed in on its high gross margin of 87.1%, strong free cash flow, and cash-heavy balance sheet, drawing extra attention ahead of the upcoming earnings release. For you as an investor, this mix of profitability metrics and an earnings catalyst raises practical questions about how Nutanix’s business model and current valuation might fit into a broader portfolio focused on software and cloud exposure. See our...

The United States market has shown robust performance with a 1.7% increase over the last week and a remarkable 34% rise over the past year, while earnings are anticipated to grow by 16% annually in the coming years. In this thriving environment, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation potential and scalability to capitalize on these favorable conditions.

Over the last 7 days, the United States market has risen by 1.7%, contributing to a remarkable 34% increase over the past year, with earnings anticipated to grow by 16% annually in the coming years. In such a thriving environment, identifying stocks that may be priced below their estimated value can present compelling opportunities for investors seeking potential growth and value.

Westlake (WLK) is back in focus after two meaningful updates: appointing Jonathan H. Baksht as incoming Chief Financial Officer and agreeing to a US$67 million settlement in the PVC Pipe Antitrust Litigation. See our latest analysis for Westlake. At a share price of US$114.28, Westlake has seen a 31.73% 90 day share price return and a 54.12% year to date share price return, while the 1 year total shareholder return sits at 26.95%. This suggests momentum has been building as investors weigh...

The United States market has shown positive momentum, with a 1.7% increase over the last week and a substantial 34% rise over the past year, alongside an anticipated annual earnings growth of 16%. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business, aligning well with current market trends.

Eldorado Gold (TSX:ELD) has closed its acquisition of Foran Mining Corporation. The deal brings the McIlvenna Bay copper project into Eldorado Gold's asset base. Foran Mining will operate as a subsidiary within Eldorado Gold following the transaction. Eldorado Gold, a gold producer listed on the TSX, now has direct exposure to the McIlvenna Bay copper project through its purchase of Foran Mining. For readers tracking miners tied to metals used in electrification and infrastructure, this...

Earlier this month, Ollie's Bargain Outlet Holdings announced plans to open 75 new stores in fiscal 2026, expanding toward an analyst-forecast footprint of about 1,300 locations over the next few years. The expansion plans arrive as investors question how effectively the retailer can handle operational challenges and current valuation risks while scaling the business. We’ll now examine how Ollie’s aggressive 2026 store expansion plans may reshape its previously optimistic investment...

For investors considering whether Ternium at around US$43.21 offers value or is already fully priced, this article breaks down what the current share price may be implying about the company. The stock has returned 1.2% over the past week, 12.8% over the past month, 10.4% year to date, and 64.9% over the last year. These figures provide useful context before weighing up what you are paying today. Recent coverage of Ternium has focused on its role in the broader metals and materials sector and...

The market has climbed 1.7% in the last 7 days and an impressive 34% over the past year, with earnings forecasted to grow by 16% annually. Investing in penny stocks—typically associated with smaller or newer companies—can still open doors to growth opportunities, especially when these stocks are supported by strong financial health. This article explores several promising penny stocks that combine balance sheet strength with long-term potential for investors seeking underappreciated growth...

Nordea Bank Abp (HLSE:NDA FI) opened 2026 with Q1 revenue of €3.0b and basic EPS of €0.32, with trailing twelve month EPS at €1.36 and net income of €4.7b underscoring the scale of its earnings base. Over recent periods, revenue has moved in a tight range around €2.8b to €3.0b per quarter, while basic EPS has stayed between €0.32 and €0.36. This gives you a clear view of how the top line and per share earnings have been tracking into the latest print. With reported net profit margins above...

Why Cigna Group Is On Investors’ Radar Today Cigna Group (CI) is back in focus after recent trading left the shares around $274.70, with mixed short term performance that includes a 1 day decline and gains over the past week and month. For investors tracking longer trends, the stock shows a negative total return over the past year alongside positive 3 year and 5 year total returns, which may encourage closer attention to how the business is currently positioned. See our latest analysis for...

The United States market has shown robust performance, rising 1.7% over the past week and climbing 34% in the last year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks with strong growth potential can offer unique opportunities for investors seeking to capitalize on emerging trends.

New Found Gold Corp. recently secured a CA$105 million senior secured credit facility from EdgePoint Capital Advisors and filed a CA$100.048 million follow-on equity offering to help fund Phase I development of its Queensway Gold Project, alongside reporting final 2025 drilling results that expanded the Dropkick Zone. Together, the financing package and confirmation that Dropkick remains open along strike and at depth highlight both funding access and geological upside for Queensway’s...

What recent performance tells you about Canadian National Railway Canadian National Railway (TSX:CNR) has seen mixed short term moves, with a 0.8% decline over the past week and a small dip on the day, along with positive returns over the past month and past 3 months. See our latest analysis for Canadian National Railway. At a share price of CA$149.68, Canadian National Railway has given investors an 8.2% 1 month share price return and a 13.15% 1 year total shareholder return, suggesting...

Leapmotor (SEHK:9863) has introduced the D19, described as the world's first premium SUV using a centralized QNX based software platform. The system integrates the digital cockpit, advanced driver assistance, and connectivity functions into a single safety certified domain. This launch marks the first mass produced vehicle to consolidate these core software defined features on advanced QNX platforms. For investors watching the electric vehicle space, this move puts software architecture at...

Wondering whether UBS Group at around CHF33.54 is still good value or starting to look stretched? This overview is built to help you frame that question clearly. The stock has had mixed recent performance, with a 0.9% decline over the last 7 days, a 14.0% gain over the last 30 days, a 12.1% decline year to date, and a 42.1% return over the last year, alongside multi year returns of 102.9% over 3 years and 172.7% over 5 years. Recent coverage of UBS Group has focused on its position as a...

Earlier this year, Lantheus Holdings secured FDA approval for its PYLARIFY TruVu imaging agent and is awaiting a separate FDA decision on its LNTH-2501 diagnostic kit, expected by late June. At the same time, projections of a 6.3% sales decline and pressure on operating margins highlight how rising costs and softer demand may temper the impact of these new products. We’ll now examine how the PYLARIFY TruVu approval, alongside projected sales headwinds, reshapes Lantheus Holdings’ existing...

If you are wondering whether DocuSign at around US$47.52 is a bargain or a value trap, the answer starts with understanding what the market might be pricing in today. The stock has recently returned 1.5% over the last 7 days, while being down 2.6% over 30 days, 26.7% year to date, 39.1% over 1 year, and 79.5% over 5 years, which gives important context before looking at any valuation numbers. These returns keep DocuSign on many investors' watchlists, as the long term share price record sits...

Investors may be wondering if Clorox at around US$96.85 is pricing in too much pessimism, or if the market is overlooking its potential value. The share price has retreated recently, with a 5.9% decline over 7 days, 8.5% over 30 days, 4.0% year to date and 27.2% over the last year. The 3 year and 5 year returns sit at 33.8% and 38.0% declines, respectively. These moves have kept Clorox on many investors' watchlists, as the stock's pullback is prompting questions about whether sentiment has...

Randstad (ENXTAM:RAND) opened 2026 with first quarter revenue of €5.5b and basic EPS of €0.35. This helps illustrate how its earnings story is developing after a year in which trailing twelve month EPS reached €1.57 on revenue of €22.9b and net income of €276m. Over the past five reported quarters, revenue has moved between €5.5b and €6.1b, while quarterly basic EPS has ranged from a loss of €0.86 to a profit of €0.50. Trailing net profit margin most recently sat at 1.2% compared with 0.4% a...

This article examines whether Science Applications International might represent value at its current share price by walking through what the numbers are actually indicating about the stock. With a share price of US$95.71 and a 16.5% gain over five years, recent returns have been softer, with the stock down 0.5% over the past week, 1.2% over the past month, 5.4% year to date and 19.0% over the last year. Recent headlines around Science Applications International have focused on its role as a...

For investors wondering whether Goodman Group at around A$29.31 is offering fair value or looking stretched, this article walks through what current prices might be implying about the stock. The share price has seen mixed returns, with a 15.6% gain over the last 30 days, a 2.9% return over 1 year and a 56.9% return over 3 years, while year to date the stock is down 4.9% and the 7-day move is a 0.7% decline. Recent coverage has focused on Goodman Group’s position within Australian real estate...